1306:TSE:TSE-Nomura TOPIX Listed (JPY)

ETF | Others |

Last Closing

USD 2842

Change

0.00 (0.00)%

Market Cap

USD 23,611.00B

Volume

2.51M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
1308:TSE Nikko TOPIX Listed

N/A

USD 11,091.37B
1321:TSE Nomura Nikkei 225 Listed

N/A

USD 11,082.14B
1305:TSE Daiwa TOPIX Listed

N/A

USD 10,799.81B
1330:TSE Nikko Nikkei 225 Listed

N/A

USD 5,423.56B
1320:TSE Daiwa Nikkei 225 Listed

N/A

USD 5,181.88B
1348:TSE MAXIS TOPIX

N/A

USD 3,383.69B
1346:TSE MAXIS Nikkei 225

N/A

USD 2,731.89B
1475:TSE iShares Core TOPIX ETF

N/A

USD 1,877.98B
1591:TSE NEXT FUNDS JPX-Nikkei Index 40..

N/A

USD 1,666.73B
1329:TSE iShares Core Nikkei 225 ETF

N/A

USD 1,529.93B

ETFs Containing 1306:TSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.85% 52% F 74% C
Dividend Return 2.34% 51% F 43% F
Total Return 17.19% 53% F 73% C
Trailing 12 Months  
Capital Gain 13.84% 50% F 71% C-
Dividend Return 2.32% 50% F 36% F
Total Return 16.16% 52% F 70% C-
Trailing 5 Years  
Capital Gain 61.66% 57% F 76% C+
Dividend Return 12.85% 48% F 51% F
Total Return 74.51% 58% F 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.46% 53% F 63% D
Dividend Return 14.46% 53% F 59% D-
Total Return 0.00% 54% F 4% F
Risk Return Profile  
Volatility (Standard Deviation) 13.34% 74% C 91% A-
Risk Adjusted Return 108.39% 77% C+ 96% N/A
Market Capitalization 23,611.00B 100% F 100% F

Annual Financials (JPY)

Quarterly Financials (JPY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike